bromodeoxyuridine has been researched along with Uterine Cervical Neoplasms in 36 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 9 (25.00) | 18.7374 |
1990's | 16 (44.44) | 18.2507 |
2000's | 9 (25.00) | 29.6817 |
2010's | 1 (2.78) | 24.3611 |
2020's | 1 (2.78) | 2.80 |
Authors | Studies |
---|---|
Çetin, İ; Topçul, M | 1 |
Bashkin, JK; Edwards, TG; Fisher, C; Fok, K; Helmus, M; Koeller, KJ; Slomczynska, U | 1 |
Baker, JH; Burston, HE; Huxham, LA; Kyle, AH; Minchinton, AI | 1 |
Chapman, W; Fykes, AW; Hill, RP; Juvet, S; Levin, W; Manchul, LA; Milosevic, M; Pintilie, M; Tsang, RW; Wong, CS | 1 |
Adamczyk, A; Gasinska, A; Kojs, Z; Szumiel, I | 1 |
Allen, S; Marker, D; Michael, E; Nees, M; Smith, L; Woodworth, CD | 1 |
Cervinka, M; Rudolf, E; Rudolf, K | 1 |
Bagshaw, MA; Doggett, RL; Kaplan, HS; Nelsen, TS; Smith, KC | 1 |
Furusawa, M; Jimi, S; Mashiba, H; Matsunaga, K; Nomura, Y; Yagawa, K; Yoshinaga, H | 1 |
Itamochi, H; Kanamori, Y; Kigawa, J; Minagawa, Y; Terakawa, N | 1 |
Flentje, M; Haas, S; Lohr, F; Wenz, F | 1 |
Bolger, BS; Cooke, TG; MacLean, AB; Stanton, PD; Symonds, RP | 1 |
Gilligan, D; McMillan, TJ; Mort, C; Ormerod, MG; Peacock, JH; Titley, J | 1 |
Cichocka, A; Gasińska, A; Pudełek, J; Skołyszewski, J; Urbański, K; Zabagło, L | 1 |
Bolger, BS; Burnett, R; Cooke, TG; Kelly, P; MacLean, AB; Stanton, PD; Symonds, RP | 1 |
Hashimoto, M; Morishita, S; Serda, D; Shimokawa, K; Takahashi, Y; Tamaya, T; Yokoyama, Y | 1 |
Biesaga, B; Gasińska, A; Jakubowicz, J; Klimek, M; Urbański, K; Wilson, GD | 1 |
Chapman, W; Fyles, AW; Li, Y; Pintilie, M; Rajaraman, MM; Tsang, RW; Wong, CS | 1 |
Chapman, W; Fyles, AW; Levin, W; Li, YQ; Manchul, LA; Milosevic, M; Pintilie, M; Tsang, RW; Wong, CS | 1 |
Eisbruch, A; Johnston, CM; Lawrence, TS; Reynolds, KR; Roberts, JA; Robertson, JM; Tworek, J | 1 |
Fyles, AW; Levin, W; Manchul, LA; Milosevic, M; Pintilie, M; Syed, A; Tsang, RW | 1 |
Bolger, B; Cooke, T; Hole, D; Mao, JH; Symonds, P | 1 |
Amellem, O; Koritzinsky, M; Pettersen, EO; Wouters, BG | 1 |
Ferlini, C; Ferrandina, G; Filippini, P; Freedman, RS; Fruscella, E; Maggiano, N; Mancuso, S; Mozzetti, S; Ranelletti, FO; Scambia, G; Stoler, AB | 1 |
Geard, CR; Tishler, RB | 2 |
Bush, C; Parkins, CS; Price, P; Steel, GG | 1 |
Erkens-Schulze, S; Knol, RF; Rozemuller, E; Rutgers, DH; van Oostrum, IE | 1 |
Fukuda, K; Hachisuga, T; Iwasaka, T; Mutoh, F; Sugimori, H; Tsugitomi, H | 1 |
Gasinska, A; Urbanski, K; Wilson, GD | 1 |
Hieda, S; Ishihara, M; Noguchi, M; Sawaguchi, K; Ueno, N; Yabushita, H | 1 |
Yoshinouchi, M | 1 |
Hirama, T; Izutsu, T; Kagabu, T; Matsuda, M; Nishiya, I; Yoshizumi, N | 1 |
Fukuda, K; Hachisuga, T; Hayashi, Y; Iwasaka, T; Sugimori, H | 1 |
Bennett, MH; Dische, S; McNally, NJ; Wilson, GD | 1 |
Cooper, GM | 1 |
1 trial(s) available for bromodeoxyuridine and Uterine Cervical Neoplasms
Article | Year |
---|---|
Bromodeoxyuridine alternating with radiation for advanced uterine cervix cancer: a phase I and drug incorporation study.
Topics: Adenocarcinoma; Adult; Aged; Biopsy; Brachytherapy; Bromodeoxyuridine; Carcinoma, Squamous Cell; Disease-Free Survival; Female; Humans; Intestinal Mucosa; Middle Aged; Neoplasm Recurrence, Local; Radiation-Sensitizing Agents; Radiotherapy Dosage; Survival Rate; Uterine Cervical Neoplasms | 1999 |
35 other study(ies) available for bromodeoxyuridine and Uterine Cervical Neoplasms
Article | Year |
---|---|
Antiproliferative Effects of EGFR inhibitor Cetuximab and PARP Inhibitor Combination on Non-Small Cell Lung Cancer Cell Line A549 and Cervical Cancer Cell Line HeLa.
Topics: Antineoplastic Agents; Bromodeoxyuridine; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cetuximab; ErbB Receptors; Female; HeLa Cells; Humans; Lung Neoplasms; Poly(ADP-ribose) Polymerase Inhibitors; Uterine Cervical Neoplasms | 2022 |
HPV episome levels are potently decreased by pyrrole-imidazole polyamides.
Topics: Antiviral Agents; Binding Sites; Bromodeoxyuridine; Cell Line, Tumor; Distamycins; DNA, Viral; Female; Human papillomavirus 16; Human papillomavirus 18; Human papillomavirus 31; Humans; Immunohistochemistry; Inhibitory Concentration 50; Microbial Sensitivity Tests; Nylons; Papillomavirus Infections; Plasmids; Pyrroles; Replication Origin; Uterine Cervical Neoplasms; Viral Load | 2011 |
Tumor distribution of bromodeoxyuridine-labeled cells is strongly dose dependent.
Topics: Animals; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Division; Dose-Response Relationship, Drug; Female; Humans; Mice; Mice, Inbred NOD; Mice, SCID; Neoplasm Transplantation; Transplantation, Heterologous; Tumor Cells, Cultured; Uterine Cervical Neoplasms | 2003 |
Pretreatment proliferation parameters do not add predictive power to clinical factors in cervical cancer treated with definitive radiation therapy.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Apoptosis; Bromodeoxyuridine; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Cell Division; Disease-Free Survival; Female; Flow Cytometry; Humans; Immunoenzyme Techniques; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Prospective Studies; Radiation-Sensitizing Agents; Survival Rate; Treatment Outcome; Uterine Cervical Neoplasms | 2003 |
Are stromal fibroblasts from cervical tumors suitable to predict normal tissue radiation reaction?
Topics: Age Factors; Aged; Apoptosis; Bromodeoxyuridine; Cell Cycle; Dose-Response Relationship, Radiation; Estradiol; Estrogens; Female; Fibroblasts; Flow Cytometry; G2 Phase; Gamma Rays; Humans; Middle Aged; Mitosis; Radiation Tolerance; S Phase; Time Factors; Uterine Cervical Neoplasms | 2004 |
Inhibition of the epidermal growth factor receptor increases expression of genes that stimulate inflammation, apoptosis, and cell attachment.
Topics: Antineoplastic Agents; Apoptosis; Blotting, Western; Bromodeoxyuridine; Cell Cycle; Cell Line, Tumor; Collagen; DNA; DNA, Complementary; Dose-Response Relationship, Drug; Down-Regulation; Enzyme Inhibitors; ErbB Receptors; Female; Gene Expression Regulation; Gene Expression Regulation, Neoplastic; Genes, Reporter; Humans; Immunoprecipitation; Inflammation; NF-kappa B; Nucleic Acid Hybridization; Oligonucleotide Array Sequence Analysis; Oligonucleotide Probes; Phosphorylation; Polymerase Chain Reaction; Quinazolines; RNA; Tyrosine; Up-Regulation; Uterine Cervical Neoplasms | 2005 |
Selenium activates p53 and p38 pathways and induces caspase-independent cell death in cervical cancer cells.
Topics: Apoptosis Inducing Factor; Apoptosis Regulatory Proteins; Bromodeoxyuridine; Caspase 3; Cell Death; Cyclin-Dependent Kinase Inhibitor p21; DNA Damage; DNA, Neoplasm; Enzyme Activation; Female; Glutathione; HeLa Cells; Humans; Intracellular Signaling Peptides and Proteins; JNK Mitogen-Activated Protein Kinases; Metalloporphyrins; Mitochondrial Proteins; Organelle Shape; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Selenium; Tumor Suppressor Protein p53; Uterine Cervical Neoplasms | 2008 |
Intra-arterial 5-bromodeoxyuridine and x-ray therapy.
Topics: Bromodeoxyuridine; Carbon Isotopes; Carcinoma, Squamous Cell; Carotid Arteries; DNA, Neoplasm; Facial Neoplasms; Female; Head and Neck Neoplasms; Humans; Infusions, Parenteral; Injections, Intra-Arterial; Male; Methotrexate; Mouth Neoplasms; Radiation-Sensitizing Agents; Uterine Cervical Neoplasms | 1967 |
Elevated cytostatic activity of monocytes from cancer patients.
Topics: Animals; Bromodeoxyuridine; Cells, Cultured; Cytotoxicity, Immunologic; Female; Head and Neck Neoplasms; Humans; Inflammation; Mice; Monocytes; Neoplasms; Phytohemagglutinins; Thymidine; Tuberculosis, Pulmonary; Uterine Cervical Neoplasms | 1981 |
Tumor cell kinetics in elderly patients with cervical cancer.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Aneuploidy; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Division; DNA, Neoplasm; Female; Flow Cytometry; Humans; Kinetics; Middle Aged; Neoplasm Staging; Staining and Labeling; Tumor Cells, Cultured; Uterine Cervical Neoplasms | 1993 |
Comparison of proliferating cell nuclear antigen (PCNA) staining and BrdUrd-labelling index under different proliferative conditions in vitro by flow cytometry.
Topics: Animals; Antibodies, Monoclonal; Bromodeoxyuridine; Cell Division; Cell Line; DNA; DNA, Neoplasm; Edetic Acid; Female; Fibroblasts; Flow Cytometry; Humans; Immunohistochemistry; Methanol; Mice; Proliferating Cell Nuclear Antigen; S Phase; Tumor Cells, Cultured; Uterine Cervical Neoplasms | 1995 |
Measurement of cell kinetics in cervical tumours using bromodeoxyuridine.
Topics: Adult; Age Factors; Biopsy; Bromodeoxyuridine; Cell Cycle; DNA, Neoplasm; Female; Flow Cytometry; Humans; Kinetics; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Ploidies; S Phase; Uterine Cervical Neoplasms | 1993 |
Application of a bromodeoxyuridine-Hoechst/ethidium bromide technique for the analysis of radiation-induced cell cycle delays in asynchronous cell populations.
Topics: Bisbenzimidazole; Bromodeoxyuridine; Cell Cycle; Cells, Cultured; Cobalt Radioisotopes; Ethidium; Female; Gamma Rays; Humans; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Uterine Cervical Neoplasms | 1996 |
Argyrophilic nucleolar organizer regions, bromodeoxyuridine labelling index and DNA ploidy in squamous cell carcinoma of the uterine cervix.
Topics: Adult; Aged; Aneuploidy; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Division; DNA, Neoplasm; Female; Humans; Middle Aged; Nucleolus Organizer Region; Prognosis; Silver Staining; Uterine Cervical Neoplasms | 1996 |
Prediction of radiotherapy response of cervical carcinoma through measurement of proliferation rate.
Topics: Aged; Bromodeoxyuridine; Cell Cycle; Cell Division; Female; Humans; Middle Aged; Multivariate Analysis; Predictive Value of Tests; Uterine Cervical Neoplasms | 1996 |
Silver-stained nucleolar organizer regions in adenocarcinoma of the cervix--a light and electron microscopic study.
Topics: Adenocarcinoma; Bromodeoxyuridine; Cervix Uteri; Epithelium; Female; Frozen Sections; Humans; Microscopy, Electron; Nucleolus Organizer Region; Paraffin Embedding; Silver Staining; Uterine Cervical Neoplasms | 1997 |
Tumour cell kinetics as a prognostic factor in squamous cell carcinoma of the cervix treated with radiotherapy.
Topics: Adult; Age Factors; Aged; Analysis of Variance; Aneuploidy; Antimetabolites; Brachytherapy; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Cycle; Cell Division; Diploidy; DNA, Neoplasm; Female; Flow Cytometry; Forecasting; Humans; Middle Aged; Multivariate Analysis; Prognosis; Proportional Hazards Models; Radiotherapy Dosage; S Phase; Survival Rate; Uterine Cervical Neoplasms | 1999 |
Tumor proliferation and apoptosis in human uterine cervix carcinoma I: correlations between variables.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Aneuploidy; Antimetabolites; Apoptosis; Biopsy; Bromodeoxyuridine; Carcinoma; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Cell Division; Diploidy; Disease Progression; Female; Flow Cytometry; Forecasting; Humans; Middle Aged; Mitosis; Neoplasm Staging; Prospective Studies; S Phase; Treatment Outcome; Uterine Cervical Neoplasms | 1999 |
Tumour proliferation and apoptosis in human uterine cervix carcinoma II: correlations with clinical outcome.
Topics: Analysis of Variance; Antimetabolites; Apoptosis; Bromodeoxyuridine; Carcinoma; Cell Division; Disease-Free Survival; Female; Flow Cytometry; Follow-Up Studies; Hemoglobins; Humans; Immunohistochemistry; Middle Aged; Mitosis; Multivariate Analysis; Neoplasm Recurrence, Local; Neoplasm Staging; Ploidies; Prognosis; Proportional Hazards Models; Prospective Studies; Remission Induction; S Phase; Survival Rate; Time Factors; Treatment Outcome; Uterine Cervical Neoplasms | 1999 |
Interrelationship of proliferation and hypoxia in carcinoma of the cervix.
Topics: Adenocarcinoma; Adult; Aged; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Division; Cell Hypoxia; Female; Humans; Middle Aged; Neoplasm Staging; Predictive Value of Tests; Prospective Studies; Uterine Cervical Neoplasms | 2000 |
Advanced-stage cervix cancer: rapid tumour growth rather than late diagnosis.
Topics: Adult; Aged; Biopsy; Bromodeoxyuridine; DNA; Female; Flow Cytometry; Humans; Middle Aged; Ploidies; Time Factors; Uterine Cervical Neoplasms; Vaginal Smears | 2000 |
Cell cycle progression and radiation survival following prolonged hypoxia and re-oxygenation.
Topics: Bromodeoxyuridine; Carcinoma; Cell Cycle; Cell Division; Cell Hypoxia; Cell Survival; Female; Flow Cytometry; Humans; Oxygen; Tumor Cells, Cultured; Tumor Stem Cell Assay; Uterine Cervical Neoplasms | 2001 |
Growth inhibitory effects and radiosensitization induced by fatty aromatic acids on human cervical cancer cells.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Apoptosis; Bromodeoxyuridine; Cell Cycle; Cell Division; Cisplatin; Combined Modality Therapy; DNA Fragmentation; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Fatty Acids; Female; Humans; Inhibitory Concentration 50; Keratins; Phenylacetates; Phenylbutyrates; Proto-Oncogene Proteins p21(ras); Radiation-Sensitizing Agents; rhoB GTP-Binding Protein; Time Factors; Tumor Cells, Cultured; Uterine Cervical Neoplasms | 2000 |
Correlation of sensitizer enhancement ratio with bromodeoxyuridine concentration and exposure time in human cervical carcinoma cells treated with low dose rate irradiation.
Topics: Bromodeoxyuridine; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Female; Humans; Radiation Dosage; Radiation Tolerance; Radiation-Sensitizing Agents; Time Factors; Tumor Cells, Cultured; Uterine Cervical Neoplasms | 1992 |
Low dose rate irradiation and halogenated pyrimidine effects on human cervical carcinoma cells.
Topics: Bromodeoxyuridine; Cell Survival; Dose-Response Relationship, Radiation; Female; Humans; In Vitro Techniques; Radiation-Sensitizing Agents; Tumor Cells, Cultured; Uterine Cervical Neoplasms | 1991 |
Cell proliferation in human tumour xenografts: measurement using antibody labelling against bromodeoxyuridine and Ki-67.
Topics: Animals; Antibodies, Monoclonal; Breast Neoplasms; Bromodeoxyuridine; Cell Cycle; Female; Humans; Immunoenzyme Techniques; Ki-67 Antigen; Male; Mice; Mice, Nude; Neoplasm Transplantation; Neoplasms; Nuclear Proteins; Urinary Bladder Neoplasms; Uterine Cervical Neoplasms | 1991 |
Cell proliferation kinetics of six xenografted human cervix carcinomas: comparison of autoradiography and bromodeoxyuridine labelling methods.
Topics: Animals; Autoradiography; Bromodeoxyuridine; Cell Cycle; Female; Flow Cytometry; Humans; Mice; Mice, Nude; Neoplasm Transplantation; Thymidine; Transplantation, Heterologous; Tritium; Uterine Cervical Neoplasms | 1990 |
Immunocytochemical detection of S-phase cells in normal and neoplastic cervical epithelium by anti-BrdU monoclonal antibody.
Topics: Antibodies, Monoclonal; Biopsy; Bromodeoxyuridine; Cell Cycle; Cervix Uteri; Epithelial Cells; Epithelium; Female; Humans; Immunohistochemistry; Interphase; Uterine Cervical Neoplasms; Vaginal Smears | 1990 |
Labelling index of gynaecological tumours assessed by bromodeoxyuridine staining in vitro using flow cytometry and histochemistry.
Topics: Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Cycle; Cell Division; Female; Flow Cytometry; Humans; Staining and Labeling; Uterine Cervical Neoplasms | 1989 |
[Experimental study on the effect of UFT with concomitant radiotherapy of uterine cervical cancer].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Division; Cell Line; Combined Modality Therapy; DNA Polymerase II; Female; Fluorouracil; Humans; Mice; Mice, Nude; Neoplasm Transplantation; Tegafur; Tumor Cells, Cultured; Uracil; Uterine Cervical Neoplasms | 1989 |
[Immunohistochemical approach to reveal the growth potential of uterine cancers using anti-BrdU antibody and Ki-67].
Topics: Adenocarcinoma; Antibodies, Monoclonal; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Nucleus; Female; Humans; Immunohistochemistry; Mitotic Index; Uterine Cervical Neoplasms; Uterine Neoplasms | 1989 |
[Cell kinetic effects of cis-platinum on cancer cells in a culture system and in cases of cervical cancer using monoclonal antibody of BrdU].
Topics: Antibodies, Monoclonal; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Cycle; Cisplatin; Female; Flow Cytometry; Humans; In Vitro Techniques; Interphase; Uterine Cervical Neoplasms | 1989 |
Immunocytochemical detection of S-phase cells in gynecologic malignancies using anti-BrdU monoclonal antibody.
Topics: Antibodies, Monoclonal; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cystadenocarcinoma; Female; Genital Neoplasms, Female; Humans; Immunohistochemistry; Interphase; Ovarian Neoplasms; Uterine Cervical Neoplasms | 1988 |
Cell proliferation in human tumours measured by in-vivo labelling with bromodeoxyuridine.
Topics: Aged; Bromodeoxyuridine; Cell Division; DNA, Neoplasm; Female; Humans; Laryngeal Neoplasms; Male; Middle Aged; Tongue Neoplasms; Uterine Cervical Neoplasms | 1988 |
Phosphorylation of 5-bromodeoxycytidine in cells infected with herpes simplex virus.
Topics: Adult; Animals; Bromides; Bromodeoxyuridine; Carcinoma; Carcinoma, Squamous Cell; Cell Line; Cell Transformation, Neoplastic; Cricetinae; Deoxycytidine; Deoxycytidine Monophosphate; Deoxyribonucleosides; Deoxyribonucleotides; DNA; DNA, Neoplasm; Female; Humans; Kidney; Laryngeal Neoplasms; Middle Aged; Phosphorus; Phosphotransferases; Simplexvirus; Tritium; Uterine Cervical Neoplasms; Viral Plaque Assay | 1973 |